Study Debunks Claims Linking Paracetamol Use to Autism Risks

A new study published in The Lancet has found no link between the use of paracetamol during pregnancy and neurodevelopmental disorders in children. This research contradicts claims made by the Trump administration in September 2023, which suggested that the common painkiller, also known as acetaminophen, could increase the risk of autism. The administration advised pregnant women to avoid the drug, causing concern among patients who have long been informed about its safety.

According to Asma Khalil, a senior researcher and professor of maternal-fetal medicine at St George’s Hospital in London, the findings from the study were consistent, stating, “paracetamol did not increase the risk” of neurodevelopmental issues. The analysis included a comprehensive review of 43 high-quality studies, all rigorously selected to avoid bias and ensure validity.

Researchers evaluated data from hundreds of thousands of participants worldwide, focusing on studies that provided detailed information on acetaminophen exposure, as well as validated medical records of the participants. They intentionally excluded studies that did not meet the established standards, ensuring that the results were based on the most reliable evidence available.

The review highlighted the importance of genetic and environmental factors in the development of neurodevelopmental disorders. Although the best studies often included sibling comparisons to assess genetic influences, such studies were scarce. Jan Haavik, a molecular neuroscientist and psychiatrist at the University of Bergen, noted, “There are many potential genetic and environmental risk factors for neurodevelopmental disorders that also should be explored.”

Despite ongoing debates surrounding the safety of Tylenol, the American College of Obstetricians and Gynecologists continues to recommend it for managing pain and fever during pregnancy. Untreated fevers have been associated with developmental issues in infants, including potential miscarriages. Conversely, other common painkillers, such as ibuprofen, can compromise blood flow to the fetus, leading to developmental complications.

The controversy over Tylenol and autism has persisted for years. In 2023, a New York judge dismissed a lawsuit against Kenvue, the manufacturer of Tylenol, from parents who claimed their child’s autism or intellectual disability was linked to the drug. The ongoing discourse has been fueled by claims from Robert F. Kennedy Jr., the current Secretary of Health and Human Services, who has long maintained that vaccines cause autism, despite this assertion lacking scientific backing.

After his recent appointment, Kennedy’s agency reported that in 2022, 1 in 31 eight-year-olds were diagnosed with autism. He mentioned that Donald Trump directed him to investigate the root causes of various childhood diseases, including autism. This directive has further intertwined the issues of medication safety and childhood developmental disorders in public discourse.

The findings from The Lancet may help clarify the misinformation surrounding paracetamol use during pregnancy, potentially easing concerns for expecting mothers. As research continues to evolve, it remains crucial for healthcare providers to communicate effectively about the implications of medication use during pregnancy, ensuring that patients receive accurate and evidence-based guidance.